Blood-brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE

Journal of Neuroimmunology

Volumn 229, Issue 1-2, 2010, Pages 180-191

  Bennett, Jami ^a   Basivireddy, Jayasree ^c   Kollar, Anita ^c   Biron, Kaan E ^a,b,c   Reickmann, Peter ^c,d   Jefferies, Wilfred A ^a,b,c   McQuaid, Stephen ^e  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d Department of Anesthesiology   (Germany)

^e ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

Blood brain barrier neuroinflammation; EAE MS; Tight junctions; Vascular permeability

Indexed keywords

PROTEIN ZO1;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; BRAIN CELL; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; FEMALE; INFLAMMATORY CELL; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TIGHT JUNCTION; VASCULAR ENDOTHELIUM;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CALCIUM-BINDING PROTEINS; CAPILLARY PERMEABILITY; CELL ADHESION MOLECULES; CELLS, CULTURED; DEXTRANS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; GLYCOPROTEINS; LIPOPOLYSACCHARIDES; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; NERVE FIBERS, MYELINATED; PEPTIDE FRAGMENTS; PERTUSSIS TOXIN; PHOSPHOPROTEINS; RECEPTORS, CELL SURFACE; SPINAL CORD; TIGHT JUNCTIONS;

EID: 78650185098     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.08.011     Document Type: Article

References (38)

1. Balabanov R., Dore-Duffy P. Role of the CNS microvascular pericyte in the blood-brain barrier. J. Neurosci. Res. 1998, 53:637-644.
2. Chang A., Tourtellotte W.W., Rudick R., Trapp B.D. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J. Med. 2002, 346:165-173.
3. Chen J., Xiao L., Rao J.N., Zou T., Liu L., Bellavance E., Gorospe M., Wang J.Y. JunD represses transcription and translation of the tight junction protein zona occludens-1 modulating intestinal epithelial barrier function. Mol. Biol. Cell 2008, 19:3701-3712.
4. Fabis M.J., Scott G.S., Kean R.B., Koprowski H., Hooper D.C. Loss of blood-brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse models. Proc. Natl Acad. Sci. USA 2007, 104:5656-5661.
5. Faulkner J., Keirstead H.S. Human embryonic stem cell-derived oligodendrocyte progenitors for the treatment of spinal cord injury. Transpl. Immunol. 2005, 15:131-142.
6. Forster C. Tight junctions and the modulation of barrier function in disease. Histochem. Cell Biol. 2008, 130:55-70.
7. Furuse M., Hirase T., Itoh M., Nagafuchi A., Yonemura S., Tsukita S., Tsukita S. Occludin: a novel integral membrane protein localizing at tight junctions. J. Cell Biol. 1993, 123:1777-1788.
8. Furuse M., Hata M., Furuse K., Yoshida Y., Haratake A., Sugitani Y., Noda T., Kubo A., Tsukita S. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J. Cell Biol. 2002, 156:1099-1111.
9. Grossman R.I., Gonzalez-Scarano F., Atlas S.W., Galetta S., Silberberg D.H. Multiple sclerosis: gadolinium enhancement in MR imaging. Radiology 1986, 161:721-725.
10. Hawkins B.T., Davis T.P. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol. Rev. 2005, 57:173-185.
11. Hochmeister S., Grundtner R., Bauer J., Engelhardt B., Lyck R., Gordon G., Korosec T., Kutzelnigg A., Berger J.J., Bradl M., Bittner R.E., Lassmann H. Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis. J. Neuropathol. Exp. Neurol. 2006, 65:855-865.
12. Keirstead H.S. Stem cells for the treatment of myelin loss. Trends Neurosci. 2005, 28:677-683.
13. Kirk J., Plumb J., Mirakhur M., McQuaid S. Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination. J. Pathol. 2003, 201:319-327.
14. Kniesel U., Wolburg H. Tight junctions of the blood-brain barrier. Cell. Mol. Neurobiol. 2000, 20:57-76.
15. Leech S., Kirk J., Plumb J., McQuaid S. Persistent endothelial abnormalities and blood-brain barrier leak in primary and secondary progressive multiple sclerosis. Neuropathol. Appl. Neurobiol. 2007, 33:86-98.
16. Lu C., Pelech S., Zhang H., Bond J., Spach K., Noubade R., Blakenhorn E.P., Teuscher C. Pertussis toxin induces angiogenesis in brain microvascular endothelial cells. J. Neurosci. Res. 2008, 86:2624-2640.
17. Mankertz J., Tavalali S., Schmitz H., Mankertz A., Riecken E.O., Fromm M., Schulzke J.D. Expression from the human occludin promoter is affected by tumor necrosis factor alpha and interferon gamma. J. Cell Sci. 2000, 113:2085-2090.
18. Matter K., Balda M.S. Holey barrier: claudins and the regulation of brain endothelial permeability. J. Cell Biol. 2003, 161:459-460.
19. McDonald W.I., Miller D.H., Thompson A.J. Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon-beta. Ann. Neurol. 1994, 36:14-18.
20. Morgan L., Shah B., Rivers L.E., Barden L., Groom A.J., Chung R., Higazi D., Desmond H., Smith T., Staddon J.M. Inflammation and dephosphorylation of the tight junction protein occludin in an experimental model of multiple sclerosis. Neuroscience 2007, 147:664-673.
21. Morita K., Sasaki M., Furuse M., Tsukita S. Endothelial claudin: claudin-5/TMVCF consitututes tight junction strands in endothelial cells. J. Cell Biol. 1999, 147:185-194.
22. Nitta T., Hata M., Gotoh S., Seo Y., Sasaki H., Hashimoto N., Furuse M., Tsukita S. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J. Cell Biol. 2003, 161:653-660.
23. Padden M., Leech S., Craig B., Kirk J., Brankin B., McQuaid S. Differences in expression of junctional adhesion molecule-A and beta-catenin in multiple sclerosis brain tissue: Increasing evidence for the role of tight junction pathology. Acta Neuropathol. 2007, 113:177-186.
24. Paty D.W., McFarland H. Magnetic resonance techniques to monitor the long term evolution of multiple sclerosis pathology and to monitor definitive clinical trials. J. Neurol. Neurosurg. Psychiatry 1998, 64(Suppl 1):S47-S51.
25. Plumb J., McQuaid S., Mirakhur M., Kirk J. Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis. Brain Pathol. 2002, 12:154-169.
26. Proescholdt M.A., Jacobson S., Tresser N., Oldfield E.H., Merrill M.J. Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats. J. Neuropathol. Exp. Neurol. 2002, 61:914-925.
27. Reijerkerk A., Kooij G., van der Pol S.M., Leyen T., van Het Hof B., Couraud P.O., Vivien D., Dijkstra C.D., de Vries H.E. Tissue-type plasminogen activator is a regulator of monocyte diapedesis through the brain endothelial barrier. J. Immunol. 2008, 181:3567-3574.
28. Silwedel C., Forster C. Differential susceptibility of cerebral and cerebellar murine brain microvascular endothelial cells to loss of barrier properties in response to inflammatory stimuli. J. Neuroimmunol. 2006, 179:37-45.
29. Simon D.B., Lu Y., Choate K.A., Velazquez H., Al-Sabban E., Praga M., Casari G., Bettinelli A., Colussi G., Rodriguez-Soriano J., McCredie D., Milford D., Sanjad S., Lifton R.P. Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science 1996, 285:103-106.
30. Sobel R.A. The extracellular matrix in multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 1998, 57:205-217.
31. Sobel R.A., Ahmed A.S. White matter extracellular matrix chondroitin sulfate/dermatan sulfate proteoglycans in multiple sclerosis. J. Neuropathol. Exp. Neurol. 2001, 60:1198-1207.
32. Turksen K., Troy T.C. Permeability barrier dysfunction in transgenic mice overexpressing claudin 6. Development 2002, 129:1775-1784.
33. van Horssen J., Bo L., Vos C.M., Virtanen I., de Vries H.E. Basement membrane proteins in multiple sclerosis-associated inflammatory cuffs: potential role in influx and transport of leukocytes. J. Neuropathol. Exp. Neurol. 2005, 64:722-729.
34. Wolburg H., Lippoldt A. Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul. Pharmacol. 2002, 38:323-337.
35. Wolburg H., Wolburg-Bucholz K., Kraus J., Rascher-Eggstein G., Liebner S., Hamm S. Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme. Acta Neuropathol. 2003, 105:586-592.
36. Wong V., Gumbiner B.M. A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier. J. Cell Biol. 1997, 136:399-409.
37. Wosik K., Cayrol R., Dodelet-Devillers A., Berthelet F., Bernard M., Moumdjian R., Bouthillier A., Reudelhuber T.L., Prat A. Angiotensin II controls occludin function and is required for blood-brain barrier maintenance: relevance to multiple sclerosis. J. Neurosci. 2007, 27:9032-9042.
38. Zamboni P., Galeotti R., Menegatti E., Malagoni A.M., Gianesini S., Bartolomei I., Mascoli F., Salvi F. A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency. J. Vasc. Surg. 2009, 50:1348-1358.e3.